SCHEMBL26961376

SCHEMBL26961376

CS(=O)(=O)N1CC2CC(c3nnc(-c4cc5c(cc4F)S(=O)(=O)C(COC(=O)N4CC6CC(c7nnc(-c8cc9c(cc8F)S(=O)(=O)C[C@H](N)C(=O)N9Cc8ccc(Cl)cc8)o7)(C6)C4)[C@H](N)C(=O)N5Cc4ccc(Cl)cc4)o3)(C2)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29796451 0.91 — —
SCHEMBL26963095 0.90 — —
SCHEMBL31142788 0.88 — —
SCHEMBL29796225 0.85 — —
SCHEMBL26963091 0.85 — —
SCHEMBL26961430 0.84 — —
SCHEMBL29796341 0.84 — —
SCHEMBL26961475 0.81 — —
SCHEMBL29796432 0.80 — —
SCHEMBL26961403 0.80 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4291558-A1 BICYCLIC TETRAHYDROAZEPINE DERIVATIVES FOR THE TREATMENT OF CANCER F. Hoffmann-La Roche AG (CH) 2023-12-20 — — EP claimed
EP-4291558-A1 BICYCLIC TETRAHYDROAZEPINE DERIVATIVES FOR THE TREATMENT OF CANCER F. Hoffmann-La Roche AG (CH) 2023-12-20 — — EP disclosed
Send feedback